Allerion
ActiveSummary
Allerion has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €88,747 and a net result of €19,515. Equity is growing by about 17% per year across the filed financial years. Its solvency ranks better than 62% of 11,063 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-09
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 61 days late
2025
29-08
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format · 29 days late
2024
30-08
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format · 30 days late
2023
31-12
Financial
Highest result from 2018 to 2025net €32,151 ▲7,990%
Operating result €41,803, net result €32,151, both a record.
31-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 31 days late
2022
31-12
Financial
Back to profitnet €397
Net result €397 after 2 loss-making years.
20-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial
Weakest financial yearnet -€5,197
Net result drops to -€5,197, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 31 days late
2020
06-10
NBB filing
Annual accounts filed
financial year 2019 · micro format · 67 days late
2019
27-06
NBB filing
Annual accounts filed
financial year 2018 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.